Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BioGlow Health vs Hims & Hers

BioGlow Health
Graded #129

Lower grade

vs+11.799999999999997
Hims & Hers
Graded #36

Higher grade

The verdict

Hims & Hers takes it — 81/100 to 69.2/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHims & Hers +12
70
82
Dose & formulationBioGlow Health +4
82
78
Clinical oversightHims & Hers +17
65
82
Labs & monitoringHims & Hers +28
52
80
FulfillmentEven
84
84
Contract termsHims & Hers +25
55
80
BioGlow Health · left barHims & Hers · right bar

The numbers

MetricBioGlow HealthHims & Hers
WeighScore69.2/10081/100
GradeCB−
Scorecard rank#129#36
Semaglutide$349/mo (compounded)$199/mo
Tirzepatide$169/mo (compounded)Not disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
BioGlow Health

Graded #129 · C

Strengths

  • Free consultation and free shipping nationwide
  • Ships compounded GLP-1s to all 50 states
  • Physician-supervised intake before any prescription
  • One platform for weight loss plus peptides, testosterone, ED and hair

Where it loses points

  • Premium pricing — compounded semaglutide starts higher than most competitors
  • Sells retatrutide, an investigational molecule the FDA has not approved
  • Prescribing clinicians and compounding-pharmacy partner not named
  • No insurance accepted — cash-pay only
  • Operating entity and credentials lightly disclosed
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard